Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics

Oct 20, 2026, 10:28 AM

Read Full Article → Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics

Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics

Translate article text

Choose a language and wait for the translated text.

Buying the UK-based biotech will add a siRNA drug candidate with high sales potential to Merck’s portfolio.

Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics | PharmaVoice